Home Nucleus Oncology France Prostate Cancer Diagnostics Market to 2032

France Prostate Cancer Diagnostics Market to 2032

Overview

The France Prostate Cancer Diagnostics Market is expected to reach a 374.27 USD Million by 2032 and is projected to grow at a CAGR of 16.88% from 2025 to 2032.

Revenue, 2024 (USD Million)
141.21
Forecast, 2032 (USD Million)
374.27
CAGR, 2024 - 2032
16.88%
Report Coverage
France

France Prostate Cancer Diagnostics Market 2018-2032 USD Million

France Prostate Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 141.21 USD Million
  • Projected Market Size (2032): 374.27 USD Million
  • CAGR (2025-2032): 16.88%

Key Findings of France Prostate Cancer Diagnostics Market

  • The France Prostate Cancer Diagnostics Market was valued at 141.21 USD Million in 2024.
  • The France Prostate Cancer Diagnostics Market is likely to grow at a CAGR of 16.88% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Prostatic Adenocarcinoma in Type Segment accounted for the largest share of the market with a revenue of 133.60 USD Million
  • The fastest growing segment Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Stage Segment grew Fastest with a CAGR of 18.83% during the forecast period from 2024 to 2032.

France Prostate Cancer Diagnostics Market Scope

France Prostate Cancer Diagnostics Market Segmentation & Scope
End User
  • Others
  • Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
  • Independent Diagnostic Laboratories
Distribution Channel
  • Retail Sales
  • Direct Tender
Age Group
  • Pediatric
  • Adult
  • Geriatrics
Type
  • Others
  • Small Cell Carcinoma
  • Prostatic Adenocarcinoma
Stage
  • Recurrent/Advanced Prostate Cancer
  • Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
  • Localized Prostate Cancer
Sample Type
  • Others
  • Urine
  • Tissue
  • Blood
Diagnostics Type
  • Confirmatory Tests
  • Preliminary Screening Tests
Product Type
  • Accessories
  • Instruments
  • Reagents & Consumables

France Prostate Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 141.21 USD Million
Market Value in 2032 374.27 USD Million
CAGR (2025-2032) 16.88%
Historic Data 2016-2023
Market Segments Covered End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type

Regional Insights:

  • Leading Market (2024-2032): France, leading in terms of revenue 141.21 USD Million in 2024
    • Key Country: France, leading in terms of revenue with value of 141.21 USD Million in 2024.

Segments and Scope

  • France Prostate Cancer Diagnostics Market to 2032, By End User
    • Independent Diagnostic Laboratories is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 93.66 USD Million in the year 2024.
    • Independent Diagnostic Laboratories is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.24 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 115.11 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.58 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Age Group
    • Geriatrics is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 120.74 USD Million in the year 2024.
    • Geriatrics is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.14 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Type
    • Prostatic Adenocarcinoma is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 133.60 USD Million in the year 2024.
    • Prostatic Adenocarcinoma is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.99 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Stage
    • Localized Prostate Cancer is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 107.37 USD Million in the year 2024.
    • Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.58 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Sample Type
    • Blood is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 111.46 USD Million in the year 2024.
    • Blood is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.22 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Diagnostics Type
    • Preliminary Screening Tests is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 109.20 USD Million in the year 2024.
    • Preliminary Screening Tests is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.44 % in forecast period 2025-2032.
  • France Prostate Cancer Diagnostics Market to 2032, By Product Type
    • Reagents & Consumables is the largest segment in France Prostate Cancer Diagnostics Market to 2032 with a revenue of 108.48 USD Million in the year 2024.
    • Reagents & Consumables is the Fastest growing segment in France Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.37 % in forecast period 2025-2032.

France Prostate Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Myriad Genetics, Inc.
OPKO Health, Inc.
Beckman Coulter, Inc.
Abbott
F. Hoffmann-La Roche Ltd.
France Prostate Cancer Diagnostics Market Company Share Analysis

France Prostate Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

France Prostate Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

France Prostate Cancer Diagnostics Market Company Profiling

France Prostate Cancer Diagnostics Market Company Profiling

Industry Related Reports

Asia-Pacific Breast Lesion Localization Methods Market
Europe Breast Lesion Localization Methods Market
North America Breast Lesion Localization Methods Market
Middle East & Africa Breast Lesion Localization Methods Market
South America Breast Lesion Localization Methods Market
Australia Breast Lesion Localization Methods Market
Belgium Breast Lesion Localization Methods Market
Brazil Breast Lesion Localization Methods Market
Canada Breast Lesion Localization Methods Market
China Breast Lesion Localization Methods Market
Frequently Asked Questions
The France Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
France Prostate Cancer Diagnostics Market was valued at USD 141.21(Revenue in USD Million) in 2022.
France Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.88% during the forecast period of 2024 to 2032.
The Prostatic Adenocarcinoma segment is expected to dominate the France Prostate Cancer Diagnostics Market, holding a largest market share of 133.60 USD Million in 2024

France Prostate Cancer Diagnostics Market Scope

France Prostate Cancer Diagnostics Market Segmentation & Scope
End User
  • Others
  • Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
  • Independent Diagnostic Laboratories
Distribution Channel
  • Retail Sales
  • Direct Tender
Age Group
  • Pediatric
  • Adult
  • Geriatrics
Type
  • Others
  • Small Cell Carcinoma
  • Prostatic Adenocarcinoma
Stage
  • Recurrent/Advanced Prostate Cancer
  • Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
  • Localized Prostate Cancer
Sample Type
  • Others
  • Urine
  • Tissue
  • Blood
Diagnostics Type
  • Confirmatory Tests
  • Preliminary Screening Tests
Product Type
  • Accessories
  • Instruments
  • Reagents & Consumables
Frequently Asked Questions
The France Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
France Prostate Cancer Diagnostics Market was valued at USD 141.21(Revenue in USD Million) in 2022.
France Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.88% during the forecast period of 2024 to 2032.
The estimated market value of the France Prostate Cancer Diagnostics Market for final year is USD 374.27 (USD Million).

France Prostate Cancer Diagnostics Market Company Profiling

France Prostate Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The France Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
France Prostate Cancer Diagnostics Market was valued at USD 141.21(Revenue in USD Million) in 2022.
France Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.88% during the forecast period of 2024 to 2032.
The estimated market value of the France Prostate Cancer Diagnostics Market for final year is USD 374.27 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES